The Academy of Medical Royal Colleges, which includes the Faculty of Pharmaceutical Medicine, recognises the need for increased transparency in relation to Conflicts of Interest in medicine and healthcare. By declaring any conflicts publicly, the Academy has long argued that transparency will be...
World Immunisation Week is a time to reflect on the importance of vaccination in preventing disease across the globe and to raise awareness of the value effective vaccination programmes can bring to the UK population.
When you google clinical trials today it brings up images of clinical settings, white coats and test tubes. But the first clinical trial was a very different experience.
Following her appearance on this week’s The Naked Scientists podcast on 'Drug Discovery', Dr Magda Papadaki, ABPI’s Head of Manufacturing Innovation, writes about realising the potential of cell and gene therapy.
Today we published our response to the GMC consultation on 'Good practice in prescribing and managing medicines and devices'.
Genetic modification and genome editing has revolutionised biomedical research in recent decades, but the discovery and application of new technologies has led to a further step change in research in the last 2-3 years.
A comment by James Anderson, Head of Corporate Government Affairs at GSK and new Chair of the ABPI Antibiotic Network.
A new report published on 18 July 2017 shows that the UK is trailing behind the rest of Europe in the treatment of cancer.
Today, March 7th sees the launch of the PRIME initiative by the European Medicines Agency. This scheme aims to strengthen support to medicines that have the potential to benefit patients who presently have no treatment options, or that may offer a major therapeutic advantage over existing treatments...
I’m not a big fan of rules (as my high school record will tell you), but I am a fan of effective regulation. That same contradiction is reflected in debates around the world, prompted simultaneously by tragedy where rules seem insufficient, and frustration where common sense seems overbearing. We...
In its Plan for Growth Review, the Government pledged to speed-up the regulatory process around clinical trials in the UK. This was welcomed by the Association of the British Pharmaceutical Industry and its members who have long called for action.